New ebook provides insights into understanding and demonstrating drug value in the current healthcare market

How are pharma, payers and patients utilizing evidence of real world outcomes to better understand and demonstrate drug value and improve patient care? How is the global market access environment changing and how is this impacting on pharmaceutical organisations? What does pharma need to know about the diverse payer landscape, alternative payment plans and communicating and influencing decision making?

These are some important questions that need answers. Health Network Communications have interviewed a number of experts from the pharmaceutical industry and payer organisations about best practice in getting the right drug, to the right patient, at the right cost and demonstrating the value of your product.  This book provides insights into what is happening now, with viewpoints from key market access and RWE stakeholders on the latest news in their area of expertise and predictions for the future of the industry.

Learn from:

• Ario Cerchiari, Senior Manager Global Market Access, Pricing and Reimbursement, Abbvie
• Clément François, VP, US Health Economics and Outcomes Research, Lundbeck
• Celia Manlove, President, Anthem BlueCross and BlueShield, Medicaid
• Jacob Drapkin, VP Reimbursement & Healthcare Economics, J&J
• Joseph Cappelleri, Senior Director, Biostatistics, Pfizer
• Sarah Priddy, Director Research, Comprehensive Health Insights, Humana
• Todd Berner, Director, Urology Health Economics & Clinical Outcomes Research, Astellas Scientific and Medical Affairs

Download ebook

Interested to hear from these industry leaders? They will all be speaking at Evidence USA 2014 in Boston this 22-23 October. Discover how pharma, payers and patients are utilizing real world evidence to understand and demonstrate drug value and improve patient care. These key stakeholders will discuss and debate the pertinent issues including payer engagement, big data, observational research, PROs, design and use of patient registries, and global and local evidence generation.